With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Restoring RUNX1 Levels in FPD/AML||University of Washington, Seattle / Marshall Horwitz, MD/PhD||Familial RUNX1 Research Grants||2016||Washington|
|Selective Epigenetic Regulation of Notch1 in T-cell Acute Lymphoblastic Leukemia||University of Michigan / Mark Yat-Fung Chiang, MD/PhD||Innovation Grants||2016||Michigan|
|Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma||University of Pennsylvania / Nicole Anderson, PhD||Young Investigator Grants||2016||Pennsylvania|
|Sepsis as innate immune stimulus: severe sepsis exposures and protection against relapse in children with acute leukemias||Children's Hospital of Philadelphia / Alix Seif, MD||Epidemiology Grants||2016||Pennsylvania|
|Child's Exposure to Radiation from Medical Imaging and the Risk of Childhood Leukemia: Pooled Analyses from the Childhood Leukemia International Consortium (CLIC)||University of California Berkeley / Catherine Metayer, MD/PhD & Steve Selvin, PhD||Epidemiology Grants||2016||California|
|Image Guided Diffuse Intrinsic Pontine Glioma Drug Delivery and Design||Weill Cornell Medical College / Mark Souweidane, MD & Richard Ting, PhD||Innovation Grants||2016||New York|
|Enhancing Pediatric Sarcoma Immunotherapy by Drug Induced Expression of Tumor-Specific Cryptic Neoantigens||University of Minnesota / David Largaespada, PhD||Innovation Grants||2016||Minnesota|
|Pre-clinical Testing of Novel Glutamine Metabolic Inhibitors in MYC-driven Medulloblastoma||The Johns Hopkins University School of Medicine / Eric Raabe, MD/PhD & Dr. Barbara Slusher, PhD||Innovation Grants||2016||Maryland|
|CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL||Children's Hospital of Philadelphia / Asen Bagashev, PhD||Young Investigator Grants||2016||Pennsylvania|
|CD47-blocking Oncolytic Vaccinia Viruses as Biotherapeutics for Pediatric Solid Tumors||St. Jude Children's Research Hospital / Stephen Gottschalk, MD & Nino Rainusso, MD||Innovation Grants||2016||Tennessee|